# Response of Fibroblastic Rheumatism to Infliximab

Authors: Ricardo Romiti; Mauricio Levy Neto; Marcello Menta Simonsen Nico
Journal: Dermatology Research and Practice
 (2009)

---

## Abstract

Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.


---

## Body


---

*Source: 715729-2010-02-01.xml*